在停止使用帕洛佩特里巴拉提后的反弹效应
Anda Mihaela Naciu1, Eleonora Sargentini1, Elena Tsourdi2
1Unit of Metabolic Bone and Thyroid Diseases, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128, Rome, Italy.
Calcified tissue international
|September 16, 2025
概括
停止治疗小甲状腺功能障碍症的palopegteriparatide可能会导致低血症. 在停止这种副甲状腺激素治疗后,仔细监测和调整和醇的剂量至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 代谢性骨疾病 代谢性骨疾病
背景情况:
- 甲状腺功能低下症 (HypoPT) 的特征是甲状腺上腺激素 (PTH) 缺乏,导致矿物质失衡.
- 传统治疗包括和维生素D;复合PTH疗法提供生理替代.
- 长期作用的PTH (1-34) 前药Pelopegteriparatide是慢性HypoPT管理的最新进展.
研究的目的:
- 描述在患有慢性hypoPT的患者中停止使用palopegteriparatide的效果.
- 突出帕洛佩特里巴拉提德治疗停止后的潜在挑战和管理策略.
主要方法:
- 一个62岁的男性患有术后的HypoPT.病例报告.
- 停止三年时间的帕洛佩特里巴拉提德治疗.
- 恢复和醇治疗,调整剂量.
- 在停止治疗后监测血清和水平.
主要成果:
- 停止治疗后一周内和的初始稳定性.
- 一个月后出现症状性低血症和高血症.
- 通过增加口服和酸剂量,成功管理低血症.
- 稳定的矿物质含量达到较低的和酸盐剂量比前palopegteriparatide治疗.
结论:
- 停止服用帕洛佩特里巴拉提德可能会导致反弹性低血症,需要谨慎管理.
- 在停止服用帕洛佩特里巴拉提时,密切监测和及时进行治疗调整至关重要.
- 这一案例强调了需要个性化治疗后患者管理策略的必要性.
相关概念视频
Therapeutic Drug Monitoring: Affecting Factors
202
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
202
Desensitization and Tachyphylaxis
3.0K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.0K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
815
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
815
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
179
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
179
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
256
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
256
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K


